Event/Regulatory approval
Completed

Lilly's orforglipron calcium tablet approved for marketing in China

Trajectories

Explore probable futures of this record — up to three arcs with a direction, a probability and a horizon.

Actors and targets

Source

礼来奥氟格列隆钙片获批上市,为国内首个口服GLP-1类减重药物。
clsvip · Telegram Open post

Related events